Submitted by Anonymous (not verified) on 30 October 2026 - 13:33
Human medicines European public assessment report (EPAR): Lemtrada, alemtuzumab, Date of authorisation: 12/09/2013, Revision: 28, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lemtrada, alemtuzumab, Date of authorisation: 12/09/2013, Revision: 28, Status: Authorised